Cargando…
A Battle against COVID-19: Vaccine Hesitancy and Awareness with a Comparative Study between Sinopharm and AstraZeneca
Background: Awareness about the COVID-19 vaccine’s adverse effects is crucial for gaining public trust. As we still lack proof of vaccines’ safety, this survey aimed to investigate Egyptians’ general awareness of the Sinopharm and AstraZeneca vaccines against COVID-19 and provide considerable eviden...
Autores principales: | Boshra, Marian S., Hussein, Raghda R. S., Mohsen, Marwa, Elberry, Ahmed A., Altyar, Ahmed E., Tammam, Mahmoud, Sarhan, Rania M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876757/ https://www.ncbi.nlm.nih.gov/pubmed/35214750 http://dx.doi.org/10.3390/vaccines10020292 |
Ejemplares similares
-
Knowledge, Attitude, and Acceptance of Sinopharm and AstraZeneca’s COVID-19 Vaccines among Egyptian Population: A Cross-Sectional Study
por: Boshra, Marian S., et al.
Publicado: (2022) -
Comparison of AstraZeneca and sinopharm vaccines as boosters in protection against COVID-19 infection
por: Letafati, Arash, et al.
Publicado: (2023) -
"Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)
por: Samir, Ahmed, et al.
Publicado: (2023) -
Comparison of side effects of the dose-1 of AstraZeneca and Sinopharm vaccines in patients with multiple sclerosis in Kermanshah, Iran (2021)
por: Razazian, Nazanin, et al.
Publicado: (2023) -
AstraZeneca COVID-19 vaccine: thrombosis with thrombocytopenia
Publicado: (2021)